Login Register Cart 0
Generic placeholder image

Protein & Peptide Letters

Editor-in-Chief

ISSN (Print): 0929-8665
ISSN (Online): 1875-5305

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Research Article

Circ_0006789 Promotes the Progression of Hepatocellular Carcinoma Cells via Modulating miR-1324 and SOX12

Author(s): Yu Cai, Yuanyuan Jia, Pu Yan, Xiaowei Chang, Wujun Li and Bin Cai*

Volume 29, Issue 10, 2022

Published on: 04 October, 2022

Page: [859 - 868] Pages: 10

DOI: 10.2174/0929866529666220823161842

Price: $65

Abstract

Background: Circular RNAs (circRNAs) exert an important regulatory effect on cancer progression. Reportedly, circRNAs can modulate gene expression by working as molecular sponges for miRNAs. Nonetheless, many functional circRNAs in hepatocellular carcinoma (HCC) remain to be identified. This study aimed to explore the role of hsa_circ_0006789 (circ_0006789) in HCC.

Methods: The expression profile of circRNAs in HCC tumor tissues was analyzed using circRNA microarray data. Circ_0006789 expression in HCC tissues and cell lines was examined by qPCR. After circ_0006789 was overexpressed or knocked down in HCC cell lines, HCC cell growth, migration and invasion were evaluated by the CCK-8 method and Transwell experiment. RIP assay, RNA pull-down assay, dual-luciferase reporter experiment and Western blotting were adopted to investigate the regulatory mechanism among circ_0006789, microRNA (miR)-1324 and SRY (sex determining region Y)-box 12 (SOX12).

Results: Circ_0006789 was overexpressed in HCC tissues and cell lines. Circ_0006789 overexpression accelerated the growth, migration and invasion of HCC cells, while knockdown of circ_0006789 exerted the opposite effects. miR-1324 was confirmed as a target of circ_0006789, and miR-1324 targeted SOX12 to suppress its expression. Circ_0006789 could promote SOX12 expression by sponging miR-1324.

Conclusion: Circ_0006789 modulates the growth, migration and invasion of HCC cells by regulating miR-1324/SOX12 axis.

Keywords: Circ_0006789, hepatocellular carcinoma, miR-1324, SOX12, circular RNAs, gene expression.

« Previous Next »
Graphical Abstract

[1]
Sung, H.; Ferlay, J.; Siegel, R.L.; Laversanne, M.; Soerjomataram, I.; Jemal, A.; Bray, F. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin., 2021, 71(3), 209-249.
[http://dx.doi.org/10.3322/caac.21660] [PMID: 33538338]
[2]
Zeng, L.; Fan, X.; Wang, X.; Deng, H.; Zhang, X.; Zhang, K.; He, S.; Li, N.; Han, Q.; Liu, Z. Involvement of NEK2 and its interaction with NDC80 and CEP250 in hepatocellular carcinoma. BMC Med. Genomics, 2020, 13(1), 158.
[http://dx.doi.org/10.1186/s12920-020-00812-y] [PMID: 33109182]
[3]
Zhou, J.; Sun, H.; Wang, Z.; Cong, W.; Wang, J.; Zeng, M.; Zhou, W.; Bie, P.; Liu, L.; Wen, T.; Han, G.; Wang, M.; Liu, R.; Lu, L.; Ren, Z.; Chen, M.; Zeng, Z.; Liang, P.; Liang, C.; Chen, M.; Yan, F.; Wang, W.; Ji, Y.; Yun, J.; Cai, D.; Chen, Y.; Cheng, W.; Cheng, S.; Dai, C.; Guo, W.; Hua, B.; Huang, X.; Jia, W.; Li, Y.; Li, Y.; Liang, J.; Liu, T.; Lv, G.; Mao, Y.; Peng, T.; Ren, W.; Shi, H.; Shi, G.; Tao, K.; Wang, W.; Wang, X.; Wang, Z.; Xiang, B.; Xing, B.; Xu, J.; Yang, J.; Yang, J.; Yang, Y.; Yang, Y.; Ye, S.; Yin, Z.; Zhang, B.; Zhang, B.; Zhang, L.; Zhang, S.; Zhang, T.; Zhao, Y.; Zheng, H.; Zhu, J.; Zhu, K.; Liu, R.; Shi, Y.; Xiao, Y.; Dai, Z.; Teng, G.; Cai, J.; Wang, W.; Cai, X.; Li, Q.; Shen, F.; Qin, S.; Dong, J. Fan, J. Liver cancer. Karger, 2020, 9(6), 682-720.
[http://dx.doi.org/10.1159/000509424] [PMID: 33442540]
[4]
Iwahashi, S.; Shimada, M.; Utsunomiya, T.; Imura, S.; Morine, Y.; Ikemoto, T.; Takasu, C.; Saito, Y.; Yamada, S. Epithelial-mesenchymal transition-related genes are linked to aggressive local recurrence of hepatocellular carcinoma after radiofrequency ablation. Cancer Lett., 2016, 375(1), 47-50.
[http://dx.doi.org/10.1016/j.canlet.2016.02.041] [PMID: 26940140]
[5]
Ebbesen, K.K.; Kjems, J.; Hansen, T.B. Circular RNAs: Identification, biogenesis and function. Biochim. Biophys. Acta, 2016, 1859(1), 163-168.
[http://dx.doi.org/10.1016/j.bbagrm.2015.07.007] [PMID: 26171810]
[6]
Lux, S.; Bullinger, L. Circular RNAs in Cancer. Adv. Exp. Med. Biol., 2018, 1087, 215-230.
[http://dx.doi.org/10.1007/978-981-13-1426-1_17] [PMID: 30259369]
[7]
Xiong, D.D.; Dang, Y.W.; Lin, P.; Wen, D.Y.; He, R.Q.; Luo, D.Z.; Feng, Z.B.; Chen, G. A circRNA-miRNA-mRNA network identification for exploring underlying pathogenesis and therapy strategy of hepatocellular carcinoma. J. Transl. Med., 2018, 16(1), 220.
[http://dx.doi.org/10.1186/s12967-018-1593-5] [PMID: 30092792]
[8]
Cai, X.; Zhao, Z.; Dong, J.; Lv, Q.; Yun, B.; Liu, J.; Shen, Y.; Kang, J.; Li, J. Circular RNA circBACH2 plays a role in papillary thyroid carcinoma by sponging miR-139-5p and regulating LMO4 expression. Cell Death Dis., 2019, 10(3), 184.
[http://dx.doi.org/10.1038/s41419-019-1439-y] [PMID: 30796202]
[9]
Han, D.; Li, J.; Wang, H.; Su, X.; Hou, J.; Gu, Y.; Qian, C.; Lin, Y.; Liu, X.; Huang, M.; Li, N.; Zhou, W.; Yu, Y.; Cao, X. Circular RNA circMTO1 acts as the sponge of microRNA-9 to suppress hepatocellular carcinoma progression. Hepatology, 2017, 66(4), 1151-1164.
[http://dx.doi.org/10.1002/hep.29270] [PMID: 28520103]
[10]
Baer, C.; Squadrito, M.L.; Laoui, D.; Thompson, D.; Hansen, S.K.; Kiialainen, A.; Hoves, S.; Ries, C.H.; Ooi, C.H.; De Palma, M. Suppression of microRNA activity amplifies IFN-γ-induced macrophage activation and promotes anti-tumour immunity. Nat. Cell Biol., 2016, 18(7), 790-802.
[http://dx.doi.org/10.1038/ncb3371] [PMID: 27295554]
[11]
Van Roosbroeck, K.; Calin, G.A. Cancer hallmarks and MicroRNAs: The therapeutic connection. Adv. Cancer Res., 2017, 135, 119-149.
[http://dx.doi.org/10.1016/bs.acr.2017.06.002] [PMID: 28882220]
[12]
Fendler, A.; Stephan, C.; Yousef, G.M.; Jung, K. MicroRNAs as regulators of signal transduction in urological tumors. Clin. Chem., 2011, 57(7), 954-968.
[http://dx.doi.org/10.1373/clinchem.2010.157727] [PMID: 21632885]
[13]
Haddad, G.; Lorenzen, J.M. Biogenesis and function of circular RNAs in health and in disease. Front. Pharmacol., 2019, 10, 428.
[http://dx.doi.org/10.3389/fphar.2019.00428] [PMID: 31080413]
[14]
Hao, S.; Lv, J.; Yang, Q.; Wang, A.; Li, Z.; Guo, Y.; Zhang, G. Identification of key genes and circular RNAs in human gastric cancer. Med. Sci. Monit., 2019, 25, 2488-2504.
[http://dx.doi.org/10.12659/MSM.915382] [PMID: 30948703]
[15]
Wang, W.; Wang, Y.; Piao, H.; Li, B.; Huang, M.; Zhu, Z.; Li, D.; Wang, T.; Xu, R.; Liu, K. Circular RNAs as potential biomarkers and therapeutics for cardiovascular disease. PeerJ, 2019, 7e6831
[http://dx.doi.org/10.7717/peerj.6831] [PMID: 31119072]
[16]
Zhang, S.J.; Chen, X.; Li, C.P.; Li, X.M.; Liu, C.; Liu, B.H.; Shan, K.; Jiang, Q.; Zhao, C.; Yan, B. Identification and characterization of circular RNAs as a new class of putative biomarkers in diabetes retinopathy. Invest. Ophthalmol. Vis. Sci., 2017, 58(14), 6500-6509.
[http://dx.doi.org/10.1167/iovs.17-22698] [PMID: 29288268]
[17]
Huang, X.Y.; Huang, Z.L.; Huang, J.; Xu, B.; Huang, X.Y.; Xu, Y.H.; Zhou, J.; Tang, Z.Y. Exosomal circRNA-100338 promotes hepatocellular carcinoma metastasis via enhancing invasiveness and angiogenesis. J. Exp. Clin. Cancer Res., 2020, 39(1), 20.
[http://dx.doi.org/10.1186/s13046-020-1529-9] [PMID: 31973767]
[18]
Zhang, X.; Xu, Y.; Qian, Z.; Zheng, W.; Wu, Q.; Chen, Y.; Zhu, G.; Liu, Y.; Bian, Z.; Xu, W.; Zhang, Y.; Sun, F.; Pan, Q.; Wang, J.; Du, L.; Yu, Y. circRNA_104075 stimulates YAP-dependent tumorigenesis through the regulation of HNF4a and may serve as a diagnostic marker in hepatocellular carcinoma. Cell Death Dis., 2018, 9(11), 1091.
[http://dx.doi.org/10.1038/s41419-018-1132-6] [PMID: 30361504]
[19]
Vishnoi, A.; Rani, S. MiRNA biogenesis and regulation of diseases: An overview. Methods Mol. Biol., 2017, 1509, 1-10.
[http://dx.doi.org/10.1007/978-1-4939-6524-3_1] [PMID: 27826912]
[20]
Xue, X.; Wang, X.; Zhao, Y.; Hu, R.; Qin, L. Exosomal miR-93 promotes proliferation and invasion in hepatocellular carcinoma by directly inhibiting TIMP2/TP53INP1/CDKN1A. Biochem. Biophys. Res. Commun., 2018, 502(4), 515-521.
[http://dx.doi.org/10.1016/j.bbrc.2018.05.208] [PMID: 29859935]
[21]
Huang, H.; Wang, X.; Wang, C.; Zhuo, L.; Luo, S.; Han, S. The miR-93 promotes proliferation by directly targeting PDCD4 in hepatocellular carcinoma. Neoplasma, 2017, 64(5), 770-777.
[http://dx.doi.org/10.4149/neo_2017_516] [PMID: 28592130]
[22]
Wang, T.; Xu, L.; Jia, R.; Wei, J. MiR-218 suppresses the metastasis and EMT of HCC cells via targeting SERBP1. Acta Biochim. Biophys. Sin. (Shanghai), 2017, 49(5), 383-391.
[http://dx.doi.org/10.1093/abbs/gmx017] [PMID: 28369267]
[23]
Amankwah, E.K.; Devidas, M.; Teachey, D.T.; Rabin, K.R.; Brown, P.A. Six candidate miRNAs associated with early relapse in pediatric B-cell acute lymphoblastic leukemia. Anticancer Res., 2020, 40(6), 3147-3153.
[http://dx.doi.org/10.21873/anticanres.14296] [PMID: 32487609]
[24]
Dong, G.; Huang, X.; Jiang, S.; Ni, L.; Ma, L.; Zhu, C.; Chen, S. SCAP mediated GDF15-induced invasion and EMT of esophageal cancer. Front. Oncol., 2020, 10564785
[http://dx.doi.org/10.3389/fonc.2020.564785] [PMID: 33123476]
[25]
Chu, Y.L. Circ_0067934 correlates with poor prognosis and promotes laryngeal squamous cell cancer progression by sponging miR-1324. Eur. Rev. Med. Pharmacol. Sci., 2020, 24(8), 4320-4327.
[PMID: 32373969]
[26]
Zhang, X.Y.; Xu, Y.Y.; Chen, W.Y. MicroRNA-1324 inhibits cell proliferative ability and invasiveness by targeting MECP2 in gastric cancer. Eur. Rev. Med. Pharmacol. Sci., 2020, 24(9), 4766-4774.
[PMID: 32432740]
[27]
Su, Y.; Lv, X.; Yin, W.; Zhou, L.; Hu, Y.; Zhou, A.; Qi, F. CircRNA Cdr1as functions as a competitive endogenous RNA to promote hepatocellular carcinoma progression. Aging (Albany NY), 2019, 11(19), 8183-8203.
[http://dx.doi.org/10.18632/aging.102312] [PMID: 31581132]
[28]
Yu, J.; Xu, Q.G.; Wang, Z.G.; Yang, Y.; Zhang, L.; Ma, J.Z.; Sun, S.H.; Yang, F.; Zhou, W.P. Circular RNA cSMARCA5 inhibits growth and metastasis in hepatocellular carcinoma. J. Hepatol., 2018, 68(6), 1214-1227.
[http://dx.doi.org/10.1016/j.jhep.2018.01.012] [PMID: 29378234]
[29]
Zhu, Q.; Lu, G.; Luo, Z.; Gui, F.; Wu, J.; Zhang, D.; Ni, Y. CircRNA circ_0067934 promotes tumor growth and metastasis in hepatocellular carcinoma through regulation of miR-1324/FZD5/Wnt/β-catenin axis. Biochem. Biophys. Res. Commun., 2018, 497(2), 626-632.
[http://dx.doi.org/10.1016/j.bbrc.2018.02.119] [PMID: 29458020]
[30]
Dy, P.; Penzo-Méndez, A.; Wang, H.; Pedraza, C.E.; Macklin, W.B.; Lefebvre, V. The three SoxC proteins--Sox4, Sox11 and Sox12--exhibit overlapping expression patterns and molecular properties. Nucleic Acids Res., 2008, 36(9), 3101-3117.
[http://dx.doi.org/10.1093/nar/gkn162] [PMID: 18403418]
[31]
Hoser, M.; Potzner, M.R.; Koch, J.M.; Bösl, M.R.; Wegner, M.; Sock, E. Sox12 deletion in the mouse reveals nonreciprocal redundancy with the related Sox4 and Sox11 transcription factors. Mol. Cell. Biol., 2008, 28(15), 4675-4687.
[http://dx.doi.org/10.1128/MCB.00338-08] [PMID: 18505825]
[32]
Wan, H.; Cai, J.; Chen, F.; Zhu, J.; Zhong, J.; Zhong, H. SOX12: A novel potential target for acute myeloid leukaemia. Br. J. Haematol., 2017, 176(3), 421-430.
[http://dx.doi.org/10.1111/bjh.14425] [PMID: 27858992]
[33]
Ding, H.; Quan, H.; Yan, W.; Han, J. Silencing of SOX12 by shRNA suppresses migration, invasion and proliferation of breast cancer cells. Biosci. Rep., 2016, 36(5)e00389
[http://dx.doi.org/10.1042/BSR20160053] [PMID: 27582508]
[34]
Du, F.; Chen, J.; Liu, H.; Cai, Y.; Cao, T.; Han, W.; Yi, X.; Qian, M.; Tian, D.; Nie, Y.; Wu, K.; Fan, D.; Xia, L. SOX12 promotes colorectal cancer cell proliferation and metastasis by regulating asparagine synthesis. Cell Death Dis., 2019, 10(3), 239.
[http://dx.doi.org/10.1038/s41419-019-1481-9] [PMID: 30858360]
[35]
Wang, L.; Hu, F.; Shen, S.; Xiao, H.; Li, G.; Wang, M.; Mei, J. Knockdown of SOX12 expression inhibits the proliferation and metastasis of lung cancer cells. Am. J. Transl. Res., 2017, 9(9), 4003-4014.
[PMID: 28979676]
[36]
Du, F.; Feng, W.; Chen, S.; Wu, S.; Cao, T.; Yuan, T.; Tian, D.; Nie, Y.; Wu, K.; Fan, D.; Xia, L. Sex determining region Y-box 12 (SOX12) promotes gastric cancer metastasis by upregulating MMP7 and IGF1. Cancer Lett., 2019, 452, 103-118.
[http://dx.doi.org/10.1016/j.canlet.2019.03.035] [PMID: 30922917]
[37]
Qu, M.; Zhu, Y.; Jin, M. MicroRNA-138 inhibits SOX12 expression and the proliferation, invasion and migration of ovarian cancer cells. Exp. Ther. Med., 2018, 16(3), 1629-1638.
[http://dx.doi.org/10.3892/etm.2018.6375] [PMID: 30186381]
[38]
Zou, S.; Wang, C.; Liu, J.; Wang, Q.; Zhang, D.; Zhu, S.; Xu, S.; Kang, M.; He, S. Sox12 Is a cancer stem-like cell marker in hepatocellular carcinoma. Mol. Cells, 2017, 40(11), 847-854.
[PMID: 29127951]
[39]
Yuan, P.; Meng, L.; Wang, N. SOX12 upregulation is associated with metastasis of hepatocellular carcinoma and increases CDK4 and IGF2BP1 expression. Eur. Rev. Med. Pharmacol. Sci., 2017, 21(17), 3821-3826.
[PMID: 28975985]
[40]
Huang, W.; Chen, Z.; Shang, X.; Tian, D.; Wang, D.; Wu, K.; Fan, D.; Xia, L. Sox12, a direct target of FoxQ1, promotes hepatocellular carcinoma metastasis through up-regulating Twist1 and FGFBP1. Hepatology, 2015, 61(6), 1920-1933.
[http://dx.doi.org/10.1002/hep.27756] [PMID: 25704764]

Rights & Permissions Print Cite
Article Metrics
1
© 2024 Bentham Science Publishers | Privacy Policy